Roger Kim, MD, MSCE, DAABIP, ATSF

Annual #LungCancer screening is associated with an increased lung cancer detection rate but decreases annually after baseline screening. @RogerKimMD @dpritzwoller @LungPRC ja.ma/4kYr3cH

🫁 Lung cancer screening saves lives, but only when the full pathway works efficiently. A new review in Current Opinion in Pulmonary Medicine highlights how lung cancer screening diagnostic efficiency can be improved across three key domains: 📌 Eligibility and uptake 📌 Adherence to annual screening 📌 Diagnostic evaluation of concerning findings Low-dose CT screening has reduced lung cancer mortality in major trials, but real-world implementation remains complex. The goal is not only to detect early-stage lung cancer. It is also to avoid diagnostic harm. That means reducing: ➡️ False negatives ➡️ False positives ➡️ Unnecessary invasive testing ➡️ Nonmalignant surgical resections ➡️ Overdiagnosis of indolent lesions ➡️ Unnecessary workup of incidental findings The review emphasizes several practical opportunities: ✅ Better identification of eligible patients ✅ Improved smoking history documentation ✅ Centralized screening programs to support adherence ✅ Standardized follow-up after positive screens ✅ Better pulmonary nodule risk assessment ✅ More coordinated invasive diagnostic pathways ✅ Careful management of subsolid nodules and incidental findings The takeaway: The future of lung cancer screening quality will depend not only on how many people are screened, but on how safely and efficiently patients move from eligibility to diagnosis, treatment, or surveillance. Reference: Caruso and Kim, Current Opinion in Pulmonary Medicine, 2026. @RogerKimMD

📢🚨Hot Off The Press🚨📢 Dr. Bischin's abstract won a scholarship from the Thoracic Oncology Assembly 🏆 Congratulations, we are proud of you!!!! @Yalepccsmfellow @caroymalo #Bestfellows #ATS2026

See you all tonight!! Come to the @atstoa business meeting to learn all the ways our Assembly has been promoting and disseminating important work in thoracic oncology!! @atscommunity @ATS_Assemblies @atsearlycareer @RogerKimMD @TejasNadig

Grateful to have participated in the @NLCRTnews #ImpSci summit, where #LungCancerScreening leaders/experts shared our work, collaborated, and workshopped issues, aims, & strategies to guide future efforts + best practices 🫁 Thx to the program committee for bringing us together!